Clinical Trials Sponsored by GlycoMimetics Incorporated

Total 1173 results

Laboratoire Chauvin
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

Dry Eye

France, Belgium
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

Sickle Cell Disease | Hemoglobinopathies | Hematological Diseases

United States, Belgium, Canada, France, Germany, Italy, United Kingdom
Bausch & Lomb Incorporated
ORA, Inc.

Completed

A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle

Allergic Conjunctivitis

United States
Encore Medical, L.P.
DJO Incorporated

Completed

Reverse Shoulder Prosthesis Prospective Multi-Center Study

Shoulder Arthropathy | Rotator Cuff Deficiency | Failed Shoulder Replacement

United States
Augusta University
Vertex Pharmaceuticals Incorporated

Completed

Longitudinal Assessment of Exercise Capacity and Vascular Function in Patients With CF

Cystic Fibrosis

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Hyperemia

United States
Encore Medical, L.P.
DJO Incorporated

Terminated

Post-Market Study of the Modular Revision Hip System (MRHS)

Traumatic Fracture | Osteolysis | Aseptic Loosening | Failed Total Hip Implant

United States
The Cleveland Clinic
DJO Incorporated

Completed

Evaluation of Electrical Nerve Stimulation (TENS) Therapy for Pain Relief Following Total Knee Arthroplasty (TKA)

Pain | Arthritis | Osteoarthritis, Knee

United States
Mayo Clinic
Celerion; Anexon, Incorporated

Completed

ANX-042 Healthy Volunteer Dose Escalation Study

Healthy Volunteers

United States
Duke University
Bausch & Lomb Incorporated

Withdrawn

Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

Neovascular Age-related Macular Degeneration

United States
NIZO Food Research
Ingredion Incorporated

Completed

Trial on Short-chain Fructooligosaccharides, Microbiota, and Constipation in Adults (TOMCAT)

Functional Constipation

Netherlands
Duke University
Cook Group Incorporated

Completed

The Use of the Bakri Postpartum Balloon in the Management of Postpartum Hemorrhage Refractory to Conservative Measures

Postpartum Hemorrhage

Kenya
Vertex Pharmaceuticals Incorporated
Tibotec, Inc

Completed

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

Hepatitis C

United States, France, United Kingdom, Germany, Canada, Netherlands, Austria, Puerto Rico
Accuray Incorporated
Centre Oscar Lambret

Terminated

CyberKnife® for Hepatic Metastases From Colorectal Cancer

Colorectal Liver Metastases

France, Germany, United Kingdom
Tibotec BVBA
Vertex Pharmaceuticals Incorporated

Completed

A Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State

Healthy Participants
The Physicians' Services Incorporated Foundation

Completed

The Effect of Bench-model Training in Cognitive Learning in the Operating Room

Sensitivity Training Groups

Canada
Vertex Pharmaceuticals Incorporated
Tibotec BVBA

Completed

Drug-Drug Interaction Study Between Telaprevir and Buprenorphine

Hepatitis C | Opioid-Related Disorders

United States
Tibotec BVBA
Vertex Pharmaceuticals Incorporated

Completed

VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers

Hepatitis C
Penn State University
Cotton Incorporated

Not yet recruiting

The Effects of Healthy Diets With Plant Oils on Heart and Metabolic Health

Cardiovascular Diseases
Ad scientiam
Vertex Pharmaceuticals Incorporated

Not yet recruiting

Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis (MuControl)

Cystic Fibrosis

France
Vertex Pharmaceuticals Incorporated
Moderna, Inc

Recruiting

A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)

Cystic Fibrosis

United States, United Kingdom, Australia, Canada
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia

Hematologic Diseases | Genetic Diseases, Inborn | Hemoglobinopathies | Thalassemia | Beta-Thalassemia

United States, United Kingdom, Canada, Germany, Italy
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Enrolling by invitation

A Long-term Follow-up Study in Participants Who Received CTX001

Hematologic Diseases | Genetic Diseases, Inborn | Sickle Cell Disease | Hemoglobinopathies | Sickle Cell Anemia | Thalassemia | Beta-Thalassemia

United States, Canada, Italy, United Kingdom, Germany
Indiana University
Erbe USA Incorporated

Completed

Post-resection Treatment of Large Colon Polyps (SAP)

Recurrence

United States
Mayo Clinic
Erbe USA Incorporated

Completed

Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe

Lung Diseases, Obstructive | Bronchi--Diseases | Lesions Mass

United States
Encore Medical, L.P.
DJO Incorporated

Terminated

Post Market Study of the 3DKnee™ With E-plus Insert (e-plus)

Osteoarthritis | Traumatic Arthritis | Degenerative Joint Disease

United States
Duke University
Bausch & Lomb Incorporated

Completed

Photodynamic Therapy for PDA in NV AMD

Macular Degeneration | Neovascular Age-related Macular Degeneration

United States
Parion Sciences
Vertex Pharmaceuticals Incorporated

Completed

A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Cystic Fibrosis

United Kingdom, United States, France, Ireland
Parion Sciences
Vertex Pharmaceuticals Incorporated

Completed

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) (CLEAN-CF)

Cystic Fibrosis

United States
Northwestern University
Bausch & Lomb Incorporated

Terminated

Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis

Herpes Zoster Keratitis

United States
Orthopaedic Research Foundation
DJO Incorporated

Completed

Early Postoperative Compex Rehab NMES Use for Total Knee Arthroplasty Patients

Knee Osteoarthritis

United States
Niconovum USA
Inflamax Research Incorporated

Completed

Oral Mucosal Effects In Adult Smokers Associated With Two Nicotine Lozenge Formulations

Safety Issues

United States
Boston Scientific Corporation
VertiFlex, Incorporated

Completed

Investigating Superion™ In Spinal Stenosis

Intermittent Claudication | Lumbar Spinal Stenosis

United States
Bausch & Lomb Incorporated
NicOx Inc.

Completed

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Primary Open Angle Glaucoma | Ocular Hypertension | Pigmentary Glaucoma | Pseudoexfoliative Glaucoma

United States
Bausch & Lomb Incorporated
Synteract, Inc.

Completed

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Keratoconjunctivitis Sicca

United States
Duke University
Bausch & Lomb Incorporated

Completed

Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD

Neovascular Age-Related Macular Degeneration

United States
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

Hyperemia

United States
Duke University
Bausch & Lomb Incorporated

Completed

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

Uveitis

United States
Encore Medical, L.P.
DJO Incorporated

Completed

Encore Revelation Hip Stem

Osteoarthritis, Hip | Complications; Arthroplasty

United States
Vertex Pharmaceuticals Incorporated
ViroChem Pharma

Completed

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Hepatitis C, Chronic

Canada
Angitia Incorporated Limited

Recruiting

A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers

Osteogenesis Imperfecta

United States
University of Georgia
Cotton Incorporated

Recruiting

Cottonseed Oil Dose Response

Dyslipidemias | Overweight and Obesity | Nutrition, Healthy

United States
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Hematologic Diseases | Genetic Diseases, Inborn | Sickle Cell Disease | Hemoglobinopathies | Sickle Cell Anemia | Thalassemia | Beta-Thalassemia

United States, Italy, Germany, Saudi Arabia
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)

Hematologic Diseases | Genetic Diseases, Inborn | Hemoglobinopathies | Thalassemia | Beta-Thalassemia

United States, Germany, Italy, United Kingdom, Canada
Centre Francois Baclesse
Accuray Incorporated

Active, not recruiting

Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life (CANAL-IMRT-01)

Locally Advanced Anal Canal Cancer

France
Insmed Incorporated
Muscular Dystrophy Association

Completed

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1

United States
Parion Sciences
Vertex Pharmaceuticals Incorporated

Completed

Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia (CLEAN-PCD)

Primary Ciliary Dyskinesia

United States, United Kingdom, Netherlands, Denmark, Canada, Italy, Germany, Poland
Accuray Incorporated
University of Pittsburgh

Unknown

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States, China
Toyos Clinic
Bausch & Lomb Incorporated

Completed

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Inflammation | Pseudophakia
Bausch & Lomb Incorporated
ORA, Inc.

Completed

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

Hyperemia

United States

Clinical Trials Sponsored by GlycoMimetics Incorporated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations